3B Blackbio Dx Ltd.

3BBLACKBIO NSE Healthcare Healthcare Service Provider
₹1,419.90
-1.62%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.01.
  • Return on equity is healthy at 19.8%.
  • Return on capital employed is healthy at 25.5%.
  • Net profit margin is strong at 42.3%.
  • Pays a dividend (yield about 0.35%).
  • Has paid a dividend in each of the last 5 years on record.
  • Promoters hold a sizeable stake (40.95%).

!Watch-points

  • Profit growth has been slow over five years (about -12% a year).
  • Sales growth has been slow over five years (about -9% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.98

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 1,219 Cr
Current Price₹ 1,419.90
High / Low₹ 1,588.90 / 1,099.50
Stock P/E21.413061
Book Value₹ 378.00
Dividend Yield0%
ROCE25.50%
ROE19.80%
Face Value₹ 10.00
Debt to Equity0.01
PEG Ratio0.71
EV / EBITDA19.71
Industry PE42.05
P/B Ratio3.656031
EPS₹ 68.27
Debt₹ 3 Cr
PAT Margin42.25%
Cash PAT₹ 65 Cr
ICR
Promoter Holding40.95%
FII Holding2.50%
DII Holding2.15%
Public Holding54.40%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 23.00%
5 Years -9.00%
3 Years 32.00%
TTM 54.00%
Compounded Profit Growth
10 Years 68.00%
5 Years -12.00%
3 Years 31.00%
TTM 13.00%
Stock Price CAGR
10 Years 58.00%
5 Years 22.00%
3 Years 20.00%
1 Year 0.00%
Return on Equity
10 Years 27.00%
5 Years 18.00%
3 Years 18.00%
Last Year 20.00%
Educational data only. Not a recommendation to buy, sell or hold any security.